4//SEC Filing
Catinazzo Thomas 4
Accession 0000950170-25-005564
CIK 0001812364other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 9:00 PM ET
Size
5.4 KB
Accession
0000950170-25-005564
Insider Transaction Report
Form 4
Catinazzo Thomas
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-10+275,000→ 275,000 totalExercise: $4.45Exp: 2035-01-09→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 10, 2025, subject to the reporting person's continued service with the Issuer through each vesting date.
Documents
Issuer
Relay Therapeutics, Inc.
CIK 0001812364
Entity typeother
Related Parties
1- filerCIK 0001818261
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 9:00 PM ET
- Size
- 5.4 KB